ASCCP guidelines and breast imaging on the heels of COVID-19
We hear from Christine Isaacs, MD about the new ASCCP guidelines and what they mean for ob/gyns.
The new ASCCP guidelines expand recommendations for cervical cancer screening to include screening every 5 years with primary high-risk human papillomavirus (hrHPV) testing. If you missed Isaacs' presentation at the 2021 ACOG ACSM, “While You Were Slee(PPE)ing: Women’s Health Updates Beyond the Pandemic’s Priorities,” read a summary here.
The guidelines were released in 2020 and, in 2021, were endorsed by the American College of Obstetricians and Gynecologists (ACOG) and the Society of Gynecologic Oncology (SGO).
Rebecca B. Perkins, MD, MSC, also presented the guidelines at ACOG’s Annual Clinical and Scientific Meeting earlier this year.
Family history criteria used to predict breast cancer genetic risk variants
September 26th 2024In a recent study, patients with a positive response to the Seven-Question Family History Questionnaire were more likely to present with a pathogenic or likely pathogenic variant in the BRCA1 and BRCA2 genes.
Read More
Offering cervical and colorectal cancer screening at breast cancer screening found effective
August 26th 2024In a recent study, women overdue for cervical cancer and colorectal cancer screening were more likely to receive coverage when offered during their breast cancer screening visit.
Read More
